title: Lateral mobility of the antagonist-occupied V2 vasopressin receptor in membranes of renal epithelial cells.
abstract: The lateral mobility of membrane integral receptors has been implicated as playing a significant role in signal transduction. The adenylate cyclase-coupled vasopressin V2 receptor has been shown to be highly laterally mobile in membranes of LLC-PK1 renal epithelial cells at physiological temperature using a fluorescent vasopressin agonist, with lateral mobility of the V2 receptor proposed to play a role in both adenylate cyclase activation and ligand induced receptor internalization and down-regulation. This study reports the synthesis and characterization of two new fluorescent antagonists [(beta-mercapto-beta,beta-cyclopentamethylene propionic acid)1,D-Tyr2,Ile4,Lys9(N6-fluoresceinylaminothiocarbonyl )]AVP (FL-AVP-anta) and [(beta-mercapto-beta,beta-cyclopentamethylene propionic acid)1,D-Tyr2,Ile4,Lys9(N6-tetramethylrhodamylaminothioca rbonyl)]AVP (TR-AVP-anta) for the V2 receptor. The latter was used to determine the parameters of lateral mobility of the V2 receptor in the non-activated antagonist-occupied form. Using fluorescence photobleaching techniques, results were largely comparable to those for agonist-occupied receptor, indicating high mobility at 37 degrees C. Antagonistic properties of the V2 receptor ligands are apparently not related to decreased receptor lateral mobility. Photobleaching measurements, however, did show that in contrast to V2 agonist, V2 antagonist did not induce receptor immobilization due to aggregation with time at 37 degrees C, indicating that this could be of mechanistic importance in the internalization process.
authors.affiliation: Max Planck Institut für Biophysik, Frankfurt, Germany.
authors.forename: I
authors.initials: I
authors.lastname: Pavo
authors.forename: D A
authors.initials: DA
authors.lastname: Jans
authors.forename: R
authors.initials: R
authors.lastname: Peters
authors.forename: B
authors.initials: B
authors.lastname: Penke
authors.forename: F
authors.initials: F
authors.lastname: Fahrenholz
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D065092:Antidiuretic Hormone Receptor Antagonists; D001127:Arginine Vasopressin / Q000031:analogs & derivatives* / Q000138:chemical synthesis / Q000494:pharmacology; D002460:Cell Line; D002462:Cell Membrane / Q000378:metabolism*; D000242:Cyclic AMP; D004848:Epithelium / Q000378:metabolism; D007668:Kidney / Q000378:metabolism*; D008969:Molecular Sequence Data; D017483:Receptors, Vasopressin / Q000378:metabolism*; D015398:Signal Transduction; D013552:Swine; D014667:Vasopressins / Q000037:antagonists & inhibitors
chemical_list: D065092:Antidiuretic Hormone Receptor Antagonists; D017483:Receptors, Vasopressin; C089396:argipressin, beta mercapto beta beta-cyclopentamethylenepropionic acid(1)-Tyr(2),Ile(4),Lys(9)(N(6)-fluoresceinylaminothiocarbonyl)-; C089397:argipressin, beta,mercapto-beta,beta-cyclopentamethylene propionic acid(1),Tyr(2),Ile(4),Lys(9)(N(6)-tetramethylrhodamylaminothiocarbonyl)-; D014667:Vasopressins; D001127:Arginine Vasopressin; D000242:Cyclic AMP